This advert is not available!
Lund University was founded in 1666 and is repeatedly ranked among the world’s top universities. The University has around 47 000 students and more than 8 800 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition.
Lund University welcomes applicants with diverse backgrounds and experiences. We regard gender equality and diversity as a strength and an asset.
The Department of Immunotechnology represents an environment with research ranging from advanced technology development to biomedical research. Main research areas include immuno-oncology, sensitization and biomarkers. Advanced technologies are used within the department, including genomics and transcriptomics, antibody development based on phage display, large-scale mass spectrometry-based proteomics, and associated bioinformatics. The Department is also responsible for several student courses and we offer high-quality education at undergraduate and graduate level. The service is directly connected to the national infrastructure within SciLifeLab and its Drug Discovery and Development Platform. About 35 people work at the Department.
Lund University is a state authority, which means you get special benefits, generous holidays and a favorable occupational pension. Lund University is a leading university, in close proximity to Denmark and continental Europe, which generates knowledge and competence for a sustainable future. We have committed and ambitious colleagues in a creative, international and dynamic work environment. If necessary, we offer help to become a resident of Sweden. Read more on the university's website about being employed by us Work with us.
The Drug Discovery and Development platform at the Science for Life Laboratory (SciLifeLab DDD) is a national infrastructure for academic drug development with the goal of translating academic discoveries into drug candidates and commercialization. The platform has been in existance for almost ten years and has contributed to more than ten start-ups and four läkemedel in clinical trials. It consists of over 40 employees distributed across six universities and runs projects in collaboration with academic researchers from all over Sweden.
Due to retirements and an increased focus on multifunctional protein therapy, two collaborative, target-oriented units at KTH and Lund University will now be restructured and we are now looking for a new Head of Unit for the SciLifeLab unit "Display and Selection Technologies" (DST) which is located at Lund University. It is part of the research environment within the Department of Immunotechnology, an environment with extensive experience in areas such as antibody technology, bioinformatics, biomarker studies and immuno-oncology. The DST group will consist of three senior researchers supported by two scientific advisors (professor level), one of whom is housed in the local research environment. The unit's primary responsibility will be to deliver characterized antibodies and derivatives thereof to projects within the platform and to develop tailored technologies for the platform.
In addition to self-designed phage display libraries (scFv and Fab), we are currently developing an antibody library based on a so-called single domain concept and we expect to develop other display platforms and machine learning/AI competencies for antibody development. The unit will have a close collaboration with the "Therapeutic Protein Engineering" unit consisting of six people at KTH, Stockholm and with other units within SciLifeLab DDD. Development activities are focused on designing new drug candidates and methods to develop these into protein-based therapy.
As the DST unit leader, you will be responsible for the overall technical planning to ensure that project-driven activities are delivered according to plan. You will also be responsible for maintaining a creative work environment in the group through coaching leadership and managing the administrative tasks assigned to the unit. You are also the key to maintaining a close collaboration with the unit at KTH. Together with the scientific leader of the platform, you will drive the development of the unit by establishing new methods and techniques, e.g. new formats for multifunctional molecules and conjugates with proximity-induced pharmaceutical effects.
Requirements for the position are:
Meritorious for the position are:
Experience from:
Great emphasis will be placed on personal skills such as organizational and leadership skills, communication skills and the ability to lead parallel projects with external partners. Consideration will also be given to how the applicant, through his(her experience and competence, is judged to complement and strengthen the Department's operations and contribute to its future development.
The employment is permanent with the extent of 100 percent with entry as soon as possible or according to agreement. Probationary employment may be applied.
The application must contain a CV and personal letter with justification as to why you are interested in the position and how the position matches your qualifications. The application should also contain a degree certificate or equivalent as well as anything else you wish to refer to (copies of grades, information for references, letters of recommendation, etc.).
You are most welcome to submit your application!
Type of employment | Permanent position |
---|---|
Contract type | Full time |
First day of employment | By agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Lund |
County | Skåne län |
Country | Sweden |
Reference number | PA2024/531 |
Contact |
|
Union representative |
|
Published | 25.Feb.2024 |
Last application date | 03.Apr.2024 11:59 PM CEST |